A Randomized Trial Testing US Food and Drug Administration "Breakthrough" Language

JAMA Intern Med. 2015 Nov;175(11):1856-8. doi: 10.1001/jamainternmed.2015.5355.

Authors

Tamar Krishnamurti¹, Steven Woloshin², Lisa M Schwartz², Baruch Fischhoff³

Affiliations

¹ Department of Engineering and Public Policy, Carnegie Mellon University, Pittsburgh, Pennsylvania.
² The Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire.
³ Department of Engineering and Public Policy, Carnegie Mellon University, Pittsburgh, Pennsylvania3Department of Social and Decision Sciences, Carnegie Mellon University, Pittsburgh, Pennsylvania.

PMID: 26390245
DOI: 10.1001/jamainternmed.2015.5355

No abstract available

Publication types

Randomized Controlled Trial

MeSH terms

Adult
Antineoplastic Agents / standards*
Drug Approval / methods*
Female
Healthy Volunteers
Humans
Lung Neoplasms / drug therapy*
Male
Surveys and Questionnaires
Terminology as Topic
Therapies, Investigational / methods
Therapies, Investigational / standards
United States
United States Food and Drug Administration

Substances

Antineoplastic Agents